Evaluation of the Relation Between Omentin-1 and Vitamin D in Postmenopausal Women With or Without Osteoporosis

Abstract

Introduction Crosstalk between bone and adipose tissues is implicated in several pathologic conditions related to bone metabolism. Omentin-1, a 34-kD protein, is released from omental adipose tissue. A few studies indicated the effect of omentin-1 on bone health and bone mineral density (BMD) and the interaction of omentin-1 with vitamin D. Therefore, this study aimed to investigate the relationship between omentin-1, vitamin D, and BMD in postmenopausal women with osteoporosis compared with non-osteoporotic counterparts.

Materials and methods Forty postmenopausal women with osteoporosis (OP), 40 counterparts without OP, and 30 premenopausal women were enrolled. Dual-energy X-ray Absorptiometry results, body mass index, and some demographic and biochemical data were recorded. Vitamin D (25-hydroxyvitamin D₃) levels were measured using liquid chromatography-tandem mass spectrometry. Serum omentin-1 was determined using an enzyme-linked immunosorbent assay.

Results Omentin-1 levels tended to increase in both postmenopausal women groups compared with the control group, but this increase was significant only in women with osteoporosis. Vitamin D levels were not different between the groups. When women were categorized according to vitamin D levels, women with normal vitamin D levels had significantly higher omentin-1 levels. A positive correlation was found between omentin-1 and vitamin D levels in all groups (r=0.197, p=0.041, n=110).

Conclusion The tendency to an increase in omentin-1 levels in postmenopausal women with osteoporosis may be due to a physiologic compensation against bone loss after menopause. The linear relationship between omentin-1 and vitamin D suggests that adipose tissue is one of the target tissues for the vitamin D effect.

Key words

omentin-1 - vitamin D - osteoporosis - bone mineral density

• References

• 1 Goulding A, Jones IE, Taylor RW. et al. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001; 139: 509-515
• 2 Lloyd JT, Alley DE, Hawkes WG. et al. Body mass index is positively associated with bone mineral density in US older adults. Arch Osteoporos 2014; 9: 175
• 3 Menzel J, di Giuseppe R, Wientzek A. et al. Physical Activity, Bone Health, and Obesity in Peri-/Pre- and Postmenopausal Women: Results from the EPIC-Potsdam Study. Calcif Tissue Int 2015; 97: 376-384
• 4 Sneve M, Emaus N, Joakimsen RM. et al. The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: The Tromso Study. Eur J Endocrinol 2008; 158: 401-409
• 5 Zaidi M, Buettner C, Sun L. et al. Minireview: The link between fat and bone: does mass beget mass?. Endocrinology 2012; 153: 2070-2075
• 6 Magni P, Dozio E, Galliera E. et al. Molecular aspects of adipokine-bone interactions. Curr Mol Med 2010; 10: 522-532
• 7 Schäffler A, Neumeier M, Herfarth H. et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102
• 8 Yang RZ, Lee MJ, Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290: E1253-E1261
• 9 Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010; 20: 143-148
• 10 Tan YL, Zheng XL, Tang CK. The protective functions of omentin in cardiovascular diseases. Clin Chim Acta 2015; 448: 98-106
• 11 Xie H, Xie PL, Luo XH. et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporos Int 2012; 23: 1425-1436
• 12 Xie H, Xie PL, Wu XP. et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res 2011; 92: 296-306
• 13 Wu SS, Liang QH, Liu Y. et al. Omentin-1 Stimulates Human Osteoblast Proliferation through PI3K/Akt Signal Pathway. Int J Endocrinol 2013; 2013: 368970
• 14 Wang D, Jiang TJ, Liao L. et al. Relationships between serum omentin-1 concentration and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 2013; 426: 64-67
• 15 Tohidi M, Akbarzadeh S, Larijani B. et al. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women. Bone 2012; 51: 876-881
• 16 Menzel J, Di Giuseppe R, Biemann R. et al. Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. J Endocrinol Invest 2016; 39: 1347-1355
• 17 Guo LJ, Jiang TJ, Liao L. et al. Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J Endocrinol Invest 2013; 36: 190-194
• 18 Assadi M, Salimipour H, Akbarzadeh S. et al. Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS One 2011; 6: e24240
• 19 Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis: report of a WHO Study Group. World Health Organ Tech Rep Ser 1994; 834: 1-129
• 20 Topçuoglu A, Uzun H, Aydin S. et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 2005; 205: 79-86
• 21 Li XP, Zeng S, Wang M. et al. Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area. J Endocrinol Invest 2014; 37: 991-1000
• 22 Zorlu M, Kiskac M, Cakirca M. et al. Evaluation of the relation between vitamin d and serum omentin and vaspin levels in women. Exp Clin Endocrinol Diabetes 2016; 124: 440-443
• 23 Ding C, Gao D, Wilding J. et al. Vitamin D signalling in adipose tissue. Br J Nutr 2012; 108: 1915-1923
• 24 Blumberg JM, Tzameli I, Astapova I. et al. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 2006; 281: 11205-11213
• 25 Freedman BI, Wagenknecht LE, Hairston KG. et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95: 1076-1083
• 26 Gao D, Trayhurn P, Bing C. 1, 25-Dihydroxyvitamin D₃ inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond) 2013; 37: 357-365